Clinical trial
Intensive Treatment For T-CELL Acute Lymphoblastic Leukemia and Advanced Stage Lymphoblastic Non-Hodgkin's Lymphoma: A Pediatric Oncology Group Phase III Study
NCT01230983 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intensive Treatment For T-CELL Acute Lymphoblastic Leukemia and Advanced Stage Lymphoblastic Non-Hodgkin's Lymphoma: A Pediatric Oncology Group Phase III Study
- Lead sponsor
- Children's Oncology Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 1996
- Completion date
- October 31, 2004
- Enrollment
- 573 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.